Fucoidan-based microneedle patch for delivery of IGF1-loaded exosomes in diabetic wound therapy.

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

• Level A · Stronger Clinical Evidence
• Level B · Emerging clinical evidence with positive signals
• Level C · Early human research exploring benefits
• Level D · Scientific groundwork from lab and animal studies
• Emerging · Emerging topic under active research

Abstract (original English)

Diabetic wounds often lead to significant therapeutic challenges due to impaired vascularization, chronic inflammation, and poor drug penetration. This study presents a polyallylamine hydrochloride-fucoidan (PAH.Fc) hydrogel-based microneedle patch for site specific delivery of IGF1-incorporated exosomal vesicles obtained from adipose-derived stem cells (ADSC-Exos) to diabetic wounds. The average size of IGF1-loaded ADSC-Exos was measured as 261.81 nm. The fabricated microneedles exhibited swelling ratios between 228.0% and 247.1%, with a degradation rate of 47.56% after 7 days of immersion in PBS. IGF1 release was sustained and time-dependent, reaching 89.25 ± 4.60% over 168 h. MTT assay confirmed cytocompatibility, with HaCaT cell viability exceeding 80% across all groups. Nile Red labeling demonstrated efficient cellular uptake of both ADSC-Exos and IGF1-loaded ADSC-Exos by HaCaT cells, and CAM assay results revealed that the PAH.Fc/IGF1 Exos induced the highest angiogenic response among tested groups. In vivo studies using a hyperglycemic rat model showed near-complete wound closure within 14 days in the PAH.Fc/IGF1 Exo-treated group, accompanied by elevated expression of VEGF and TGF-β and reduced levels of pro-inflammatory markers TNF-α and IL-1β. Collectively, these findings demonstrate that the PAH.Fc/IGF1 Exo microneedle patch offers optimized local delivery of bioacti

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.